Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b

NCT05401305 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Haemophilus Influenzae Infection
Vaccines

Interventions

BIOLOGICAL: Vaccine for the prevention of infections caused by Haemophilus influenza type b
BIOLOGICAL: Placebo

Sponsor

St. Petersburg Research Institute of Vaccines and Sera